NAVB
Price:
$0.000099999997
Market Cap:
$100.00
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (PET), gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. It...[Read more]
Industry
Biotechnology
IPO Date
1992-11-10
Stock Exchange
OTC
Ticker
NAVB
According to Navidea Biopharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.00. This represents a change of -99.93% compared to the average of -0.68 of the last 4 quarters.
The mean historical PE Ratio of Navidea Biopharmaceuticals, Inc. over the last ten years is -3.77. The current -0.00 PE Ratio has changed -98.67% with respect to the historical average. Over the past ten years (40 quarters), NAVB's PE Ratio was at its highest in in the March 2017 quarter at 0.27. The PE Ratio was at its lowest in in the September 2016 quarter at -599.32.
Average
-3.77
Median
-3.65
Minimum
-7.87
Maximum
0.77
Discovering the peaks and valleys of Navidea Biopharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 189.20%
Maximum Annual PE Ratio = 0.77
Minimum Annual Increase = -240.44%
Minimum Annual PE Ratio = -7.87
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.41 | -83.77% |
| 2021 | -2.50 | -47.80% |
| 2020 | -4.79 | 189.20% |
| 2019 | -1.66 | 52.63% |
| 2018 | -1.09 | -240.44% |
| 2017 | 0.77 | -111.16% |
| 2016 | -6.92 | -5.08% |
| 2015 | -7.29 | -7.29% |
| 2014 | -7.87 | 33.26% |
| 2013 | -5.91 | -38.58% |
The current PE Ratio of Navidea Biopharmaceuticals, Inc. (NAVB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.57
5-year avg
-2.09
10-year avg
-3.77
Navidea Biopharmaceuticals, Inc.’s PE Ratio is greater than Generex Biotechnology Corporation (-0.00), greater than WPD Pharmaceuticals Inc. (-99.29), greater than Nanomix Corporation (-0.00), less than NeonMind Biosciences Inc. (0), greater than Gelesis Holdings, Inc. (-0.20), greater than MobileSmith, Inc. (-0.00), less than Goodbody Health Limited (-0.00), greater than Gene Biotherapeutics, Inc. (-0.00), greater than MagForce AG (-329.76), greater than Acorda Therapeutics, Inc. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $0 | |
| -99.29 | $140.00 | |
| -0.00 | $9.80K | |
| 0 | $8.54K | |
| -0.20 | $7.33K | |
| -0.00 | $8.52K | |
| -0.00 | $365.00 | |
| -0.00 | $6.49K | |
| -329.76 | $11.97K | |
| -0.00 | $12.42K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Navidea Biopharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Navidea Biopharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Navidea Biopharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Navidea Biopharmaceuticals, Inc. (NAVB)?
What is the highest PE Ratio for Navidea Biopharmaceuticals, Inc. (NAVB)?
What is the 3-year average PE Ratio for Navidea Biopharmaceuticals, Inc. (NAVB)?
What is the 5-year average PE Ratio for Navidea Biopharmaceuticals, Inc. (NAVB)?
How does the current PE Ratio for Navidea Biopharmaceuticals, Inc. (NAVB) compare to its historical average?